Literature DB >> 12522559

Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).

Bárbara Meléndez1, Sandra Rodríguez-Perales, Beatriz Martínez-Delgado, Ignacio Otero, Mercedes Robledo, Angel Martínez-Ramírez, Sergio Ruiz-Llorente, Miguel Urioste, Juan Cruz Cigudosa, Javier Benítez.   

Abstract

An alternative model has been proposed for the development of clear-cell renal cell carcinoma (RCC) in families where chromosome 3 translocations segregate with the disease. In this model, the existence of a translocation involving chromosome 3 would favour the non-disjunctional loss of the derivative chromosome carrying the 3p segment. Additionally, subsequent somatic mutations in the VLH gene, located in 3p25-26, would inactivate this tumour suppressor gene. In the present work, we describe a new family with two clear-cell RCC affected members and a t(3;8)(p13;q24.1) translocation in two consecutive generations. We observed loss of the derivative chromosome carrying the 3p segment (der(8)) and somatic mutation of the VHL gene in the left-kidney tumoral tissue of the proband. His right-kidney tumour carried a different VHL mutation and loss of heterozygosity (LOH) was not detected. The mother of the proband was also clear-cell RCC-affected but the tumoral tissue analysed did not carry any VHL gene mutations. Another member of the family, a maternal aunt, had a papillary RCC and did not carry this translocation, the LOH on 3p or the VHL somatic mutations. Haplotype analysis of the three affected members revealed that they did not inherit a common region on 3p, confirming the different genetic origin of both tumour types. Finally, the presence of RCC in other non-available members of the family highlights the overall risk for RCC in families with chromosome 3 translocations. In the present work, we have confirmed the proposed mechanism for the development of clear-cell RCC in this family, although we cannot discard the existence of other genes, in addition to VHL, being involved in hereditary RCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12522559     DOI: 10.1007/s00439-002-0848-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  5 in total

1.  Case report: renal cell carcinoma segregating with a t(2;3)(q37.3;q13.2) chromosomal translocation in an Ashkenazi Jewish family.

Authors:  L McKay; M Frydenberg; L Lipton; F Norris; I Winship
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

2.  Characterization of a 3;6 translocation associated with renal cell carcinoma.

Authors:  Rebecca E Foster; Mahera Abdulrahman; Mark R Morris; Elena Prigmore; Susan Gribble; Beeling Ng; Dean Gentle; Steven Ready; Phil M T Weston; Michael S Wiesener; Takeshi Kishida; Masahiro Yao; Val Davison; Jose Luis Barbero; Carol Chu; Nigel P Carter; Farida Latif; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

3.  Renal cell cancer among African Americans: an epidemiologic review.

Authors:  Loren Lipworth; Robert E Tarone; Joseph K McLaughlin
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

Review 4.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

Review 5.  Characterization of renal cell carcinoma-associated constitutional chromosome abnormalities by genome sequencing.

Authors:  Philip S Smith; James Whitworth; Hannah West; Jacqueline Cook; Carol Gardiner; Derek H K Lim; Patrick J Morrison; R Gordon Hislop; Emily Murray; Marc Tischkowitz; Anne Y Warren; Emma R Woodward; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2020-02-05       Impact factor: 5.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.